Seeking Alpha

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - Capecitabine and 5-FU are used for the treatment of colorectal, esophageal, stomach, ...
Nasdaq

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...
WDAF-TV

Genemarkers Pharmacogenomic (PGx) Testing Panels Earn Approval from New York State - CLEP

"Genemarkers is accredited by CAP and holds a NY State Permit for PGX testing. This allows Genemarkers to offer PGx testing in all 50 states and demonstrates they adhere to the highest regulatory ...
News Medical

Integrating PGx testing for personalized prostate cancer treatment

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...
Healio

Integration of pharmacist-led pharmacogenomics testing in cardiology clinical practice

Please provide your email address to receive an email when new articles are posted on . Pharmacists can play a key role in integrating pharmacogenomics data into clinical practice. Antiplatelet, ...
Lexington Herald Leader

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug ...

STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA ...